# Nucala

NDC: 0173-0892
Generic name: mepolizumab
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20190606

FDA application: BLA761122

## Active ingredients

- MEPOLIZUMAB: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0173-0892"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0892
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fefb887c-e4ac-431e-8893-e9d1a5a63fea
